Deep TMS technology has created a new era in brain disorder treatment. A unique non-drug treatment based on magnetic brain stimulation, it brings substantial improvement without causing systemic or long-term side effects such as those caused by antidepressants.
Brainsway Deep TMS has been proven to be effective for patients with severe, presistent depression who tried several medications without success.
Brainsway’s unique technology is based on patents registered by the National Institute of Health (NIH) and by the company. It has received an FDA clearance for treating depression and a variety of additional indications from health institutions worldwide such as the CE and ANVISA.
For more information please visit www.brainsway.com
Brainsway Deep TMS has been proven to be effective for patients with severe, presistent depression who tried several medications without success.
Brainsway’s unique technology is based on patents registered by the National Institute of Health (NIH) and by the company. It has received an FDA clearance for treating depression and a variety of additional indications from health institutions worldwide such as the CE and ANVISA.
For more information please visit www.brainsway.com
Location: United States, Massachusetts, Burlington
Employees: 51-200
Founded date: 2003
Investors 1
| Date | Name | Website |
| - | Shavit Cap... | shavitcapi... |
Mentions in press and media 19
| Date | Title | Description |
| 22.07.2026 | Bluegrass Advanced Mental Health Opens in Louisville, Expanding Options for Patients with Treatment-Resistant Depression | Bluegrass Advanced Mental Health Combining triple-board certified expertise with local roots, Dr. David Roth launches a new physician-led practice focused on interventional psychiatric care. Too many people have been told they've tried ever... |
| 07.07.2026 | BrainsWay Featured in USA Today America250 Segment Highlighting Future of Mental Health Treatment and Neuromodulation | Advances in neuromodulation are challenging conventional approaches and expanding non‑drug treatment options for depression and other mental health conditions BURLINGTON, MA, UNITED STATES, July 7, 2026 /EINPresswire.com/ -- BrainsWay Ltd. ... |
| 18.05.2026 | BrainsWay: $1.5 Million Investment In Hopemark Health To Expand Access To Interventional Psychiatry Care | BrainsWay announced a strategic minority-stake investment in Hopemark Health as part of its broader strategy to expand awareness of and access to advanced interventional psychiatry treatments across North America. Under the terms of the agr... |
| 31.03.2026 | Neurolief Secures Major Funding for At-Home Depression Therapy | Neurolief secures $6M from BrainsWay. FDA approved its ProlivRx system. This brain neuromodulation therapy treats major depressive disorder at home. It targets patients resistant to antidepressants. The investment fuels U.S. rollout. It vas... |
| 30.03.2026 | Neurolief: $6 Million Investment Raised For FDA-Approved At-Home Depression Neuromodulation Therapy | Neurolief, a neuroscience-driven medical technology company focused on non-invasive neuromodulation therapies, has secured a $6 million milestone-based investment from BrainsWay following FDA Premarket Approval of its ProlivRx system. The f... |
| 30.03.2026 | Neurolief Raises Additional $6M Investment | Neurolief Proliv Rx Neurolief, a Coral Springs, FL-based medical technology company developing neuromodulation therapies for mental health conditions, raised a $6M investment from BrainsWay Ltd. The news followed the FDA Premarket Approval ... |
| 02.07.2024 | Patients on these antidepressants were more likely to gain weight, study says | New research is comparing the weight changes of patients taking different types of antidepressants, one of the most commonly prescribed medications in the United States. The study, published on Tuesday in the Annals of Internal Medicine, an... |
| 06.03.2024 | BrainsWay Reports Fourth Quarter and Full-Year 2023 Financial Results and Operational Highlights | - |
| 21.03.2023 | Spiritual Awakening Arrives as Masses Attend Asbury Campus Revival and Jesus Revolution Movie | Australian College Students Christen Prophetic Book Prior to Revival This book is more than a good read; it's an operating manual for success. We should be teaching this to our young adults and future leaders” — David CaspilloSILICON VALLEY... |
| 16.09.2022 | Cigna extends coverage for Brainsway’s brain stimulation device to treat OCD | Obsessive-Compulsive Disorder (OCD) has been ranked by the World Health Organization as one of the top 10 most debilitating medical conditions in terms of loss of income and decreased quality of life. The condition is a complex one that pre... |
Show more